4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-015284
Chief Operating Officer sold 42,500 shares at $19.99 ($849,575)
- Chief Operating Officer acquired 42,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GIVEN BRUCE D Chief Operating Officer | 2019-03-01 | Option exercise | +42,500 | $2.01 | $85,425 | 687,106 | D |
| GIVEN BRUCE D Chief Operating Officer | 2019-03-01 | Sale | −42,500 | $19.99 | $849,575 | 644,606 | D |
| Derivatives | |||||||
| GIVEN BRUCE D Chief Operating Officer | 2019-03-01 | Option exercise · Stock Option (right to buy) | −42,500 | 350,000 | D | ||
| Open-market sales · 42,500 sh · avg $19.99 · $849,575 | |||||||
Loading xslF345X03/doc4.xml…